Navigation Links
Rensselaer professor utilizing New York state grant to study adult stem cells

Troy, N.Y. Rensselaer Polytechnic Institute Assistant Professor of Biomedical Engineering Deanna Thompson is utilizing more than $300,000 in New York state funding as part of the state stem cell research program, NYSTEM, to study adult neural stem cells. The NYSTEM program is New York's $600 million publicly funded grant program to advance scientific discovery in the area of stem cells.

Working at the interface of engineering and neuroscience, her research is helping scientists and doctors develop new stem cell therapies and research tools utilizing these important cells. The adult stems cells she is investigating could play an important role in understanding and treating a variety of brain illnesses, from cancer and Alzheimer's to traumatic brain injury and stroke.

"Dr. Thompson is a young, rising star in her field and has come up with a highly innovative approach to direct, cause, and control nerve regeneration through stem cell bioengineering," said Rensselaer Biomedical Engineering leader Deepak Vashishth. "The results of her NYSTEM-funded research will provide unique insight into the stem cell niche and help develop new tools and therapies for regenerative medicine."

Neural stem cells are a specialized type of stem cell that can be found in the adult nervous system. These stem cells have the potential to repair or replace damaged nerve cells. For researchers, the ability to generate new cells or repair damaged nerve cells would be exceptionally helpful to heal a traumatic brain injury following an accident or reverse the cellular death caused by an illness like Parkinson's disease. Thompson's research is working to understand exactly how neural stem cells proliferate or differentiate into new nerve cells in the brain so that ability can be replicated to develop new medical treatments.

In order to control stem cell fate or differentiation, she must first understand the complex environment surrounding the stem cells. This environment or "niche" contains vascular and other cells, proteins, carbohydrates, and other cell products. In this niche, stem cells multiply in an orderly manner and can differentiate into new nerve cells or other non-nerve cells in the brain known as glia. Without the key control elements of the niche, a stem cell might multiply quickly, turning from a promising cure to a cancerous tumor. Without a clear understanding of the stem cell niche, a medical treatment involving stem cells could be very risky.

An element of the stem cell niche that Thompson is studying with this round of NYSTEM funding is endothelial cells. These cells line the interior of blood vessels, which are highly concentrated in the regions of the brain where neural stem cells reside. In particular, Thompson is looking at how materials produced by endothelial cells during their development influence neural stem cells' fate. According to Thompson, such control could allow for the development of stem cell therapies grown from an individual patient's own neural stem cells.

To perform her research, Thompson will utilize the resources of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer.

"Deanna's work, which is at the interface of cell biology and materials science, epitomizes the interdisciplinary research within CBIS," said CBIS Director and the Howard P. Isermann '42 Professor of Chemical and Biological Engineering Jonathan Dordick. "By studying the physiology and function of adult stem cells in a synthetic niche, Deanna has identified key determinants of neuronal cell growth and differentiation. Her work has impacted the burgeoning field of regenerative medicine and has helped CBIS make a name for itself in this critical research area."

Her work with brain cells has several other important implications beyond stem cell therapies. Another facet of her research as a member of National Science Foundation-funded Rensselaer Nanoscale Science and Engineering Center for Directed Assembly of Nanostructures involves the use of nanotechnology to repair damaged nerves in the brain and spinal cord.

"Professor Thompson's work in the Center for Directed Assembly of Nanostructures has addressed both the use of nanotubes in directing neuron growth and investigated the toxicity of carbon nanotubes in potential new medical therapies," said Linda Schadler, associate dean for academic affairs in the School of Engineering and professor in the Department of Materials Science and Engineering. "The ability to direct neuron growth is exciting in terms of helping patients repair damaged nerves. Through her work, she was also one of the first to recognize the role of glial cells in neuron growth, which may be the key to bringing this exciting technology to fruition."


Contact: Gabrielle DeMarco
Rensselaer Polytechnic Institute

Related biology news :

1. Student innovation at Rensselaer holds key to safer remote detection of dangerous materials
2. Rensselaer Polytechnic Institute professor Georges Belfort wins biochemical engineering award
3. Rensselaer researcher wins prestigious American Cancer Society award for work on cancer
4. Rensselaer professors Dordick and Interrante named ACS Fellows
5. Purifying proteins: Rensselaer researchers use NMR to improve drug development
6. Rensselaer professor uncovers mysterious workings of cholera bacteria
7. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
8. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
9. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
10. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
11. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
Post Your Comments:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... JOLLA, Calif. , Oct. 29, 2015  The ... a new report titled, "DNA Synthesis and Biosecurity: Lessons ... well the Department of Health and Human Services guidance ... issued in 2010. --> ... but it also has the potential to pose unique ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... the remaining 11,000 post-share consolidation (or 1,100,000 pre-share ... "Series B Warrants") subject to the previously disclosed ... 23, 2015, which will result in the issuance ... to the issuance of such shares, there will ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... InSphero AG, ... 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... Aregger served on the management team and was promoted to Head of ...
(Date:11/24/2015)... LOS ANGELES , Nov. 24, 2015 ... a biotechnology company focused on the discovery, development and ... Marban , Ph.D., Chief Executive Officer, is scheduled to ... December 1, 2015 at 10:50 a.m. EST, at The ... York City . . ...
(Date:11/24/2015)... NEW YORK , November 24, 2015 ... in a European healthcare ... in which the companies will work closely together in identifying ... of unmet medical need. The collaboration is underpinned by a ... LSP fund. This is the first investment by Bristol-Myers Squibb ...
Breaking Biology Technology: